Ilyang to go global

Published: 2010-05-04 06:58:00

Updated: 2010-05-04 06:58:00

Ilyang Pharm is reported to enter into a distribution agreement with a leading multinational drug manufacturer to expand the sales of its new anticerant “ilaprazole” on a global basis.

Under the proposed contract, Ilyang will export ilaprazole as a finished form and the production will be made...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK